Credit Suisse’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $2.23M | Sell |
23,460
-227,868
| -91% | -$21.1M | ﹤0.01% | 1778 |
|
|
2023
Q4 | $22.4M | Sell |
251,328
-93,741
| -27% | -$6.96M | 0.02% | 634 |
|
|
2023
Q3 | $25.2M | Buy |
345,069
+88,762
| +35% | +$7.09M | 0.03% | 582 |
|
|
2023
Q2 | $21.3M | Buy |
256,307
+30,634
| +14% | +$2.56M | 0.02% | 645 |
|
|
2023
Q1 | $17.2M | Sell |
225,673
-244,213
| -52% | -$20.3M | 0.02% | 719 |
|
|
2022
Q4 | $39M | Buy |
469,886
+13,985
| +3% | +$1.13M | 0.04% | 470 |
|
|
2022
Q3 | $36.2M | Buy |
455,901
+203,663
| +81% | +$17.2M | 0.04% | 488 |
|
|
2022
Q2 | $18.7M | Sell |
252,238
-2,363
| -0.9% | -$177K | 0.02% | 709 |
|
|
2022
Q1 | $22.9M | Buy |
254,601
+96,268
| +61% | +$8.89M | 0.02% | 711 |
|
|
2021
Q4 | $17.7M | Buy |
158,333
+123,109
| +350% | +$14.8M | 0.01% | 1150 |
|
|
2021
Q3 | $4.43M | Sell |
35,224
-323,646
| -90% | -$41.7M | ﹤0.01% | 2166 |
|
|
2021
Q2 | $48.6M | Buy |
358,870
+349,069
| +3,562% | +$45.9M | 0.04% | 709 |
|
|
2021
Q1 | $1.33M | Sell |
9,801
-70,952
| -88% | -$10.6M | ﹤0.01% | 3113 |
|
|
2020
Q4 | $11.4M | Sell |
80,753
-17,639
| -18% | -$2.26M | 0.01% | 1494 |
|
|
2020
Q3 | $11M | Sell |
98,392
-48,264
| -33% | -$5.41M | 0.01% | 1329 |
|
|
2020
Q2 | $16.4M | Buy |
146,656
+1,823
| +1% | +$180K | 0.02% | 1048 |
|
|
2020
Q1 | $11.2M | Sell |
144,833
-45,635
| -24% | -$4.04M | 0.01% | 1123 |
|
|
2019
Q4 | $18.1M | Sell |
190,468
-734,528
| -79% | -$63.5M | 0.02% | 1083 |
|
|
2019
Q3 | $70.5M | Buy |
924,996
+785,388
| +563% | +$65.3M | 0.08% | 336 |
|
|
2019
Q2 | $12.2M | Sell |
139,608
-332,312
| -70% | -$28.3M | 0.02% | 1199 |
|
|
2019
Q1 | $42.7M | Buy |
471,920
+116,791
| +33% | +$9.94M | 0.06% | 488 |
|
|
2018
Q4 | $25.5M | Buy |
355,129
+249,328
| +236% | +$20.1M | 0.04% | 663 |
|
|
2018
Q3 | $10.1M | Buy |
105,801
+36,816
| +53% | +$3.57M | 0.01% | 1249 |
|
|
2018
Q2 | $6.57M | Sell |
68,985
-17,090
| -20% | -$1.57M | 0.01% | 1539 |
|
|
2018
Q1 | $7.55M | Buy |
86,075
+32,270
| +60% | +$2.95M | 0.01% | 1424 |
|
|
2017
Q4 | $4.57M | Sell |
53,805
-1,204,808
| -96% | -$101M | 0.01% | 1834 |
|
|
2017
Q3 | $109M | Buy |
1,258,613
+1,142,911
| +988% | +$91.6M | 0.14% | 192 |
|
|
2017
Q2 | $8.93M | Sell |
115,702
-326,420
| -74% | -$23.2M | 0.01% | 1265 |
|
|
2017
Q1 | $30.7M | Buy |
442,122
+404,740
| +1,083% | +$27.2M | 0.03% | 623 |
|
|
2016
Q4 | $2.21M | Sell |
37,382
-1,543,665
| -98% | -$95.3M | ﹤0.01% | 2363 |
|
|
2016
Q3 | $105M | Buy |
1,581,047
+526,832
| +50% | +$32.6M | 0.12% | 198 |
|
|
2016
Q2 | $57M | Buy |
1,054,215
+23,507
| +2% | +$1.29M | 0.07% | 322 |
|
|
2016
Q1 | $53.2M | Sell |
1,030,708
-403,428
| -28% | -$21M | 0.07% | 320 |
|
|
2015
Q4 | $101M | Sell |
1,434,136
-558,966
| -28% | -$38.1M | 0.12% | 177 |
|
|
2015
Q3 | $124M | Buy |
1,993,102
+751,660
| +61% | +$59.2M | 0.16% | 133 |
|
|
2015
Q2 | $104M | Buy |
1,241,442
+637,002
| +105% | +$49.5M | 0.11% | 205 |
|
|
2015
Q1 | $45.4M | Buy |
604,440
+131,502
| +28% | +$9.19M | 0.05% | 468 |
|
|
2014
Q4 | $29.4M | Sell |
472,938
-293,832
| -38% | -$16.8M | 0.03% | 693 |
|
|
2014
Q3 | $39.9M | Sell |
766,770
-31,875
| -4% | -$1.63M | 0.04% | 606 |
|
|
2014
Q2 | $41M | Sell |
798,645
-1,321,461
| -62% | -$59.6M | 0.04% | 576 |
|
|
2014
Q1 | $101M | Buy |
2,120,106
+2,015,463
| +1,926% | +$103M | 0.12% | 195 |
|
|
2013
Q4 | $4.54M | Sell |
104,643
-128,406
| -55% | -$5.32M | 0.01% | 1926 |
|
|
2013
Q3 | $10M | Sell |
233,049
-96,927
| -29% | -$3.93M | 0.01% | 1132 |
|
|
2013
Q2 | $11.5M | Buy |
+329,976
| New | +$11.6M | 0.02% | 1053 |
|
Other funds holding XBI
ACA